A. Milford Ward

3.0k total citations
89 papers, 2.2k citations indexed

About

A. Milford Ward is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, A. Milford Ward has authored 89 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in A. Milford Ward's work include Liver Diseases and Immunity (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). A. Milford Ward is often cited by papers focused on Liver Diseases and Immunity (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). A. Milford Ward collaborates with scholars based in United Kingdom, United States and Denmark. A. Milford Ward's co-authors include Malcolm W. Greaves, Kevin Spencer, John Lorber, J T Whicher, James W.F. Catto, Freddie C. Hamdy, E.J. Coombes, Charles R. Stewart, M.R.C. Path and Jessica Williams and has published in prestigious journals such as The Lancet, Cancer and Gut.

In The Last Decade

A. Milford Ward

85 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Milford Ward United Kingdom 28 443 423 336 287 248 89 2.2k
Stuart C. Finch United States 28 229 0.5× 221 0.5× 445 1.3× 137 0.5× 242 1.0× 101 2.9k
Harold R. Schumacher United States 28 881 2.0× 570 1.3× 408 1.2× 83 0.3× 333 1.3× 122 2.8k
Francesco Perfumo Italy 32 172 0.4× 354 0.8× 684 2.0× 366 1.3× 220 0.9× 145 3.6k
L Morel-Marogér France 33 545 1.2× 271 0.6× 719 2.1× 111 0.4× 276 1.1× 131 3.1k
Theodore J. Pysher United States 27 140 0.3× 374 0.9× 764 2.3× 354 1.2× 210 0.8× 86 2.6k
Dorothy M. Painter Australia 26 314 0.7× 731 1.7× 190 0.6× 159 0.6× 598 2.4× 70 2.5k
Hirokazu Imai Japan 25 374 0.8× 234 0.6× 623 1.9× 71 0.2× 203 0.8× 138 2.4k
Ruth Andrea Seeler United States 25 114 0.3× 280 0.7× 336 1.0× 434 1.5× 153 0.6× 93 2.3k
Elliot Alpert United States 34 247 0.6× 804 1.9× 852 2.5× 462 1.6× 1.1k 4.4× 124 4.0k
Henrik Birgens Denmark 35 295 0.7× 249 0.6× 560 1.7× 547 1.9× 276 1.1× 96 3.6k

Countries citing papers authored by A. Milford Ward

Since Specialization
Citations

This map shows the geographic impact of A. Milford Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Milford Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Milford Ward more than expected).

Fields of papers citing papers by A. Milford Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Milford Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Milford Ward. The network helps show where A. Milford Ward may publish in the future.

Co-authorship network of co-authors of A. Milford Ward

This figure shows the co-authorship network connecting the top 25 collaborators of A. Milford Ward. A scholar is included among the top collaborators of A. Milford Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Milford Ward. A. Milford Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cevikbas, Ferda, A. Milford Ward, & Karen A. Veverka. (2024). Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic Dermatitis. BioDrugs. 38(6). 821–830. 1 indexed citations
2.
Ward, A. Milford, James W.F. Catto, & Freddie C. Hamdy. (2001). Prostate specific antigen: biology, biochemistry and available commercial assays. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 38(6). 633–651. 118 indexed citations
3.
Wild, G., et al.. (2000). Assessment of latex allergy in a healthcare population: are the available tests valid?. Clinical & Experimental Allergy. 30(10). 1444–1449. 27 indexed citations
4.
Lolin, Yvette & A. Milford Ward. (1995). Alpha- 1-antitrypsin phenotypes and associated disease patterns in neurological patients. Acta Neurologica Scandinavica. 91(5). 394–398. 16 indexed citations
5.
Wong, Elizabeth, N Eftekhari, Malcolm W. Greaves, & A. Milford Ward. (1987). Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. British Journal of Dermatology. 116(4). 553–556. 44 indexed citations
6.
Fifield, R, et al.. (1987). Total IgE and Allergen-Specific IgE Assays: Guidelines for the Provision of a Laboratory Service. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 24(3). 232–245. 9 indexed citations
7.
Buamah, P K, et al.. (1986). Serum alpha fetoprotein kinetics in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 16(1). 75–7. 2 indexed citations
8.
Lorber, John & A. Milford Ward. (1985). Spina bifida--a vanishing nightmare?. Archives of Disease in Childhood. 60(11). 1086–1091. 40 indexed citations
9.
BREATHNACH, S.M., et al.. (1983). Symptomatic dermographism: Natural history, clinical features, laboratory investigations and response to therapys. Clinical and Experimental Dermatology. 8(5). 463–476. 65 indexed citations
10.
Whicher, J T, Christopher P. Price, Kevin Spencer, & A. Milford Ward. (1982). Immunonephelometric and Immunoturbidimetric Assays for Proteins. CRC Critical Reviews in Clinical Laboratory Sciences. 18(3). 213–260. 64 indexed citations
11.
Triger, D. R., Clive Charlton, & A. Milford Ward. (1982). What does the antimitochondrial antibody mean?. Gut. 23(10). 814–818. 19 indexed citations
12.
Hancock, B. W., et al.. (1982). Immunity in Hodgkin's disease: status after 5 years' remission. British Journal of Cancer. 46(4). 593–600. 9 indexed citations
13.
Hancock, Barry W., et al.. (1979). The effects of radiotherapy on immunity in patients with localized carcinoma of the cervix uteri. Cancer. 43(1). 118–123. 8 indexed citations
14.
Hancock, B. W., Lesley J. Bruce, A. Milford Ward, & John C. Richmond. (1976). Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease.. BMJ. 1(6005). 313–315. 22 indexed citations
15.
Ward, A. Milford & F. E. Preston. (1974). The Kidney and Intravascular Coagulation in Myelomatosis. BMJ. 2(5918). 529–531. 7 indexed citations
16.
17.
Ward, A. Milford & J. C. E. Underwood. (1973). Alpha 1 antitrypsin deficiency and liver disease in childhood.. BMJ. 1(5856). 758.1–758. 1 indexed citations
18.
Ward, A. Milford, et al.. (1973). Oxyphil adenoma of the laryngeal ventricle. The Journal of Laryngology & Otology. 87(6). 583–585. 6 indexed citations
19.
Preston, F E & A. Milford Ward. (1972). Acute renal failure in myelomatosis from intravascular coagulation.. BMJ. 1(5800). 604–605. 6 indexed citations
20.
Ward, A. Milford, et al.. (1967). Diagnostic value of liver function tests andEntamoeba histolyticaantibody studies in East Africans. Journal of Clinical Pathology. 20(2). 180–184. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart C. Finch Breakdown of academic impact, for papers by Harold R. Schumacher Breakdown of academic impact, for papers by Francesco Perfumo Breakdown of academic impact, for papers by L Morel-Marogér Breakdown of academic impact, for papers by Theodore J. Pysher Breakdown of academic impact, for papers by Dorothy M. Painter Breakdown of academic impact, for papers by Hirokazu Imai Breakdown of academic impact, for papers by Ruth Andrea Seeler Breakdown of academic impact, for papers by Elliot Alpert Breakdown of academic impact, for papers by Henrik Birgens
Rankless by CCL
2026